Drug Discovery
Researchers have discovered that combining silybin and carvedilol is more effective against liver fibrosis than either drug alone. The pair targets key drivers of liver scarring, reducing collagen buildup in experimental models. Both drugs are already approved for other uses, paving the way for quick clinical testing.
An Ruwaito ta hanyar AI
US-based Insilico Medicine, backed by Fosun and Tencent, is expanding its research base in China to develop an AI-powered drug-discovery tool called Pharma.AI. Founder Alex Zhavoronkov likened the tool to an “Einstein” capable of advancing drug discovery into new frontiers.